Latest News From "The Pink Sheet" DAILY

Glaxo Buys A Stake In Intercell And Gains Access To Patch Vaccine Techology

As part of the deal, the big drug maker gets the right to market experimental patch vaccines for traveler's diarrhea and pandemic flu.   read more

 

Cymbalta's Chronic Pain Woes Continue As Advisory Committee Faces Cancellation

Indication would be major expansion of the market for Lilly's SSNRI, but the application has already been withdrawn once.   read more

 

Part D Expansion Surfaces In Senate With Medicare Buy-In Proposal

Senate leadership weighs allowing uninsured individuals ages 55 to 64 to buy in to Medicare as part of health care reform.   read more

 

Nippon Chemiphar Parts Ways With Ranbaxy, Takes Over Generics Venture

The June takeover of Ranbaxy by Daiichi Sankyo sparked speculation over whether the joint venture would end.   read more

 

EU Pharma Reorganization Leaves Questions About How R&D Will Be Supported

The transfer of EU pharma policy from the Commission's Enterprise department to its Health Directorate may be less negative for industry than some fear.   read more

 

"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here